Merck & Co. at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Merck & Co. brings 2 presentations to SfN 2026 in Washington. Its presentations centre on Alzheimer’s disease, myelin loss and pain-target discovery. One thread links plaque-associated stress in oligodendrocytes with myelin loss.

OrganizationSfN 2026 Attendance
Merck & Co.
Cambridge, MA
merck.com
Drug developers
Pharmaceutical company developing medicines and conducting neuroscience research.
Talk
Sun Nov 15
10:15–10:30am
Poster
Tue Nov 17
1–5pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Merck & Co.

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction